Stocktoria
Keros Therapeutics, Inc. KROS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-04-08
Keros Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 2,513,244 | $114.9M |
| CITADEL ADVISORS LLC | 553,766 | $6.1M |
| D. E. Shaw & Co., Inc. | 509,608 | $5.6M |
| RENAISSANCE TECHNOLOGIES LLC | 453,482 | $5.0M |
| AQR CAPITAL MANAGEMENT LLC | 406,563 | $4.5M |
| TWO SIGMA INVESTMENTS, LP | 363,835 | $4.0M |
| Point72 Asset Management, L.P. | 109,015 | $1.2M |
| MILLENNIUM MANAGEMENT LLC | 106,858 | $1.2M |
Source: SEC EDGAR filings · CIK 0001664710 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.